Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44347 clinical trials with a EudraCT protocol, of which 7375 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,347)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,347 result(s) found. Displaying page 201 of 2,218.

EudraCT Number: 2009-012676-27

Sponsor Protocol Number: FemExp-I

Start Date*: 2010-01-24

Sponsor Name:Wallenberg laboratory

Full Title: Femoral-Express-I

Medical condition: Peripheral artery disease. Patients due for by-pass surgery of lower extremity arteries.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10034638	Peripheral vascular disorders NEC	HLT
	12.0		10003611	Atherosclerosis of arteries of the extremities, unspecified	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-005178-10

Sponsor Protocol Number: AM-101-CL-08-01

Start Date*: 2009-01-27

Sponsor Name:Auris Medical AG

Full Title: Efficacy of AM 101 in Patients with Acute Inner Ear Tinnitus: A Multi-Centre, Double-Blind, randomised, Placebo-Controlled, Multiple Dose, Group Comparison Phase II Study

Medical condition: Acute inner ear tinnitus following acute acoustic trauma, sudden deafness, or acute otitis media.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10013993 - Ear and labyrinth disorders	10043882	Tinnitus	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) BE (Completed) NL (Completed)

Trial results: View results

EudraCT Number: 2010-020170-42

Sponsor Protocol Number: 12708A

Start Date*: 2012-10-05

Sponsor Name:H. Lundbeck A/S

Full Title: An open-label study evaluating the Pharmacokinetics and Tolerability of Lu AA21004 in connection with multiple oral dosing of Lu AA21004 in child and adolescent patients with a DSM-IV-TRTM diagnosi...

Medical condition: DSM-IV-TRTM diagnosed Depressive or Anxiety Disorder

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10037175 - Psychiatric disorders	10002861	Anxiety disorders and symptoms	HLGT
	14.1	10037175 - Psychiatric disorders	10012401	Depressive disorders	HLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2010-020171-23

Sponsor Protocol Number: 4SC-201-3-2010

Start Date*: 2010-10-04

Sponsor Name:4SC AG

Full Title: A phase I/II study to evaluate safety, tolerability, pharmacokinetics and efficacy of resminostat (4SC-201) in combination with a second-line treatment in patients with k-ras mutated advanced color...

Medical condition: Advanced or metastasized colorectal carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	15.1	100000004864	10010036	Colorectal carcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2010-020174-42	Sponsor Protocol Number: ZonMw11510009	Start Date*: 2011-11-04
Sponsor Name:ZonMw
Full Title: Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized study
Medical condition: Bone metastases
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-000221-22	Sponsor Protocol Number: BANDY 070112	Start Date*: 2007-10-15
Sponsor Name:John Pernow
Full Title: Effect of bosentan on macro- and microvascular function in patients with type 2 diabetes
Medical condition: Type 2 diabetes and albuminuria.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-000232-12	Sponsor Protocol Number: SYNC-01-AC-P1	Start Date*: 2007-01-31
Sponsor Name:Syntopix Group plc
Full Title: Novel topical therapies for acne vulgaris: a randomised, controlled, double blind comparison of the antibacterial efficacy of 1% w/v formulations of tert-butylhydroquinone, zinc pyrithione and benz...
Medical condition: Healthy volunteer study. The product under development will be used for the treatment of acne vulgaris.
Disease:
Population Age: Adolescents, Under 18, Adults		Gender: Male
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2007-000236-16

Sponsor Protocol Number: IPX056-B06-03

Start Date*: 2007-05-28

Sponsor Name:IMPAX Laboratories, Inc.

Full Title: A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects with Establis...

Medical condition: Established Spasticity Resulting from Multiple Sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10041416	Spasticity	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: EE (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2010-021785-30

Sponsor Protocol Number: A4001095

Start Date*: 2011-12-07

Sponsor Name:ViiV Healthcare UK Limited

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...

Medical condition: HIV infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004862	10068341	HIV-1 infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) SE (Prematurely Ended) FI (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) AT (Completed) DK (Prematurely Ended) NL (Completed) PT (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2008-001579-32

Sponsor Protocol Number: RHF0001

Start Date*: 2008-09-22

Sponsor Name:University of Hertfordshire

Full Title: Erectile dysfunction:a randomised controlled trial of lipid lowering with simvastatin (EDS trial)

Medical condition: Erectile dysfunction

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10061461	Erectile dysfunction	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2010-019505-42	Sponsor Protocol Number: LEG-SIL-LTX-03	Start Date*: 2010-05-26
Sponsor Name:Rottapharm SpA
Full Title: ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LEGALON SIL EN EL TRATAMIENTO DE LA RECURRENCIA DE VHC EN EL INJERTO DE PACIENTES SOMETIDOS A UN T...
Medical condition: Pacientes de 18-70 años afectados por VHC en espera de de un trasplante ortotópico de hígado / 18-70 years old patients affected by HCV awaiting orthotopic liver transplantation
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-019513-24	Sponsor Protocol Number: 10_022	Start Date*: 2011-03-03
Sponsor Name:London School of Hygiene & Tropical Medicine
Full Title: Antibiotics for exacerbations of chronic obstructive pulmonary disease: a pilot randomised trial within the General Practice Research Database
Medical condition: Diagnosed at a GP visit as suffering from acute exacerbation of COPD a. Medical history of COPD b. Increase in dyspnoea AND increase of (non-purulent) sputum volume
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2010-019527-58	Sponsor Protocol Number: 010506	Start Date*: 2011-05-24
Sponsor Name:NHS Lothian [...] 1. NHS Lothian 2. University of Edinburgh
Full Title: EMPIRE-Elafin Myocardial Protection from Ischaemia RepErfusion injury
Medical condition: Myocardial ischaemia reperfusion injury Post-operative inflammation Post-ischaemic inflammatory injury
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2009-018005-43

Sponsor Protocol Number: 205.419

Start Date*: 2010-06-14

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG

Full Title: A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat® inhaler (2.5 and 5 μg once ...

Medical condition: Moderate persistent asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10003553	Asthma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2008-004351-29

Sponsor Protocol Number: 2008-02-IMP-5

Start Date*: 2008-12-18

Sponsor Name:HEXAL AG

Full Title: OPEN LABEL, MULTICENTER STUDY ON PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF GOSERELIN 10.8 mg IMPLANT HEXAL IN PATIENTS WITH ADVANCED HORMONE DEPENDENT PROSTATE CANCER

Medical condition: Palliative treatment of advanced hormone dependent prostate cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10060862	Prostate cancer	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: BG (Completed)

Trial results: View results

EudraCT Number: 2008-004393-40

Sponsor Protocol Number: TG-MV-007

Start Date*: 2008-12-17

Sponsor Name:ThromboGenics NV

Full Title: A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion.

Medical condition: Focal Vitreomacular Adhesion

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10051065	Vitreomacular traction syndrome	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) GB (Completed) DE (Completed) CZ (Completed) ES (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2008-004398-16

Sponsor Protocol Number: W10-046

Start Date*: 2008-10-08

Sponsor Name:Abbott Scandinavia AB

Full Title: A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable RA Patients in Clinical remission

Medical condition: Adalimumab has the indication for life-long treatment of RA but can adalimumab be discontinued in patients who are in stable clinical remission (DAS28<2.6) with retained low disease activity or wil...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10028395 - Musculoskeletal and connective tissue disorders	10039073	Rheumatoid arthritis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2009-014409-15

Sponsor Protocol Number: CRFB002DPT04T

Start Date*: 2010-01-08

Sponsor Name:AIBILI - Association for Innovation and Biomedical Research on Light and Image

Full Title: Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis plus panret...

Medical condition: Proliferative Diabetic Retinopathy.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10036857	Proliferative diabetic retinopathy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PT (Completed)

Trial results: View results

EudraCT Number: 2009-010288-17	Sponsor Protocol Number: 1516	Start Date*: 2009-07-13
Sponsor Name:Karolinska Hospital
Full Title: Breast cell turnover and mammographic density in women with Polycystic Ovary Syndrome (PCOS)
Medical condition: Polycystic ovary syndrome (PCOS) is the most common hormonal aberration in women of fertile age, with a prevalence of 5-10%, and is associated with chronic anovulation, hyperandrogenism and PCO mo...
Disease:
Population Age: Adults		Gender: Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-019759-23

Sponsor Protocol Number: PET-CT140410

Start Date*: 2011-01-12

Sponsor Name:Guys' and St. Thomas' NHS Foundation Trust

Full Title: Evaluation of [11C]-methionine positron emission computerised tomography (PET CT) in diagnosing neurofibromatosis 1(NF1) - malignant peripheral nerve sheath tumours (MPNST)

Medical condition: The diagnosis of malignant peripheral nerve sheath tumours in patients with neurofibromatosis 1

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12		10029268	Neurofibromatosis 1 associated malignant peripheral nerve sheath tumour	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Wed Jul 09 05:50:28 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA